Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform

Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding from Illumina, Inc.

Please to read the entire article.